Differentiation of Mountain- and Garden-Cultivated Ginseng with Different Growth Years Using HS-SPME-GC-MS Coupled with Chemometrics
-
Published:2023-02-21
Issue:5
Volume:28
Page:2016
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Zhang Luoqi123, Wang Ping2, Li Sen4, Wu Dan2, Zhong Yute123, Li Weijie2, Xu Haiyu25, Huang Luqi3
Affiliation:
1. College of Traditional Chinese Medicine, Jilin Agricultural University, Changchun 130118, China 2. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China 3. National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China 4. Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China 5. Key Laboratory for Research and Evaluation of TCM, National Medical Products Administration, China Academy of Chinese Medical Sciences, Beijing 100700, China
Abstract
Although there are differences in the appearance of Mountain-Cultivated Ginseng (MCG) and Garden-Cultivated Ginseng (GCG), it is very difficult to distinguish them when the samples are processed to slices or powder. Moreover, there is significant price difference between them, which leads to the widespread adulteration or falsification in the market. Thus, the authentication of MCG and GCG is crucial for the effectiveness, safety, and quality stability of ginseng. In the present study, a headspace solid-phase microextraction gas chromatography mass spectrometry (HS-SPME-GC-MS) coupled with chemometrics approach was developed to characterize the volatile component profiles in MCG and GCG with 5-,10-,15-growth years, and subsequently to discover differentiating chemical markers. As a result, we characterized, for the first time, 46 volatile components from all the samples by using the NIST database and the Wiley library. The base peak intensity chromatograms were subjected to multivariate statistical analysis to comprehensively compare the chemical differences among the above samples. MCG5-,10-,15-years and GCG5-,10-,15-years samples were mainly divided into two groups by unsupervised principal component analysis (PCA), and 5 potential cultivation-dependent markers were discovered based on orthogonal partial least squares-discriminant analysis (OPLS-DA). Moreover, MCG5-,10-,15-years samples were divided into three blocks, and 12 potential growth-year-dependent markers enabled differentiation. Similarly, GCG5-,10-,15-years samples were also separated into three groups, and six potential growth-year-dependent markers were determined. The proposed approach could be applied to directly distinguish MCG and GCG with different growth years and to identify the differentiation chemo-markers, which is an important criterion for evaluating the effectiveness, safety, and quality stability of ginseng.
Funder
Scientific and technological the National Natural Science Foundation of China Scientific and technological innovation project of the China Academy of Chinese Medical Sciences Fundamental Research Funds for the Central public Welfare Research Institutes Intergovernmental Cooperation in International Science and Technology Innovation
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference26 articles.
1. Current evaluation of the millennium phytomedicine—Ginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations;Jia;Curr. Med. Chem.,2009 2. Li, S., Zhang, Y., Yang, P., Tong, M., Xing, L., Zhang, Q., Bi, K., and Li, Q. (2021). An Integrated Mutually Oriented “Chemical Profiling-Pharmaceutical Effect” Strategy for Screening Discriminating Markers of Underlying Hepatoprotective Effects to Distinguish Garden-Cultivated from Mountain-Cultivated Ginseng. Molecules, 26. 3. Characterization of the Components and Pharmacological Effects of Mountain-Cultivated Ginseng and Garden Ginseng Based on the Integrative Pharmacology Strategy;Li;Front. Pharmacol.,2021 4. Production of bioactive plant secondary metabolites through in vitro technologies-status and outlook;Wawrosch;Appl. Microbiol. Biotechnol.,2021 5. TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome;Wang;Front. Pharmacol.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|